Serum PSA
Comparison Between Tru-Cut Biopsy And Serum Psa Levels In The Diagnosis Of Carcinoma Prostate
... with Serum PSA and out of these, 50 patients who had Serum PSA > 4 ng/dl, were selected for the study and they were evaluated with digital rectal examination followed by comparison with ...
6
Urinary PSA: a potential useful marker when serum PSA is between 2 5 ng/mL and 10 ng/mL
... prostatectomy. Serum PSA and uri- nary PSA were again obtained at their first postoperative follow-up ...age, serum PSA and prostate volumes were used to ana- lyze ...
5
<p>The Value of Prostate-Specific Antigen-Related Indexes and Imaging Screening in the Diagnosis of Prostate Cancer</p>
... the PSA alone has low sensitivity and speci fi city in the diagnosis of ...the serum PSA level is above the normal range in approxi- mately 21 – 47% of BPH patients, and a high PSA level leads ...
6
Autologous dendritic cells transfected with prostate specific antigen RNA stimulate CTL responses against metastatic prostate tumors
... namely PSA, is available for monitoring disease ...decreased serum PSA velocities upon initiation of vaccine ...with PSA RNA–transfected DCs represents a novel approach for prostate cancer ...
10
Incidence of high chromogranin A serum levels in patients with non metastatic prostate adenocarcinoma
... cancer. PSA is an important tool for detecting prostate ...of serum PSA in assessing the treat- ment efficacy in patients with hormone-refractory dis- ease did not correlate with changes in pain ...
5
Original Article An inverse association of obesity and prostate-specific antigen in elderly males
... and PSA, especially BMI and WC as a continuous variable in crude and age, FBG or PV adjusted ...on serum PSA levels after age adjusted and PSAD and PSAR for males older than 60 years, in which age ...
8
Clinical Stage Evaluation at Diagnosis of Prostate Cancer at Urology Andrology Clinic Cnhu Hkm Cotonou
... Aims: To evaluate the clinical stage at diagnosis of prostate cancer. Materials and Methods: This study was retrospective and descriptive from January 2008 to June 2013. Patients who were diag- nosed with prostate cancer ...
5
Efficacy of Serum Prostate Specific Antigen (PSA), Digital Rectal Examination (DRE) and 12-core Transrectal ultrasound (TRUS) guided biopsy in detecting Carcinoma Prostate
... of serum PSA (prostate specific antigen), DRE (digital rectal examination), & TRUS (transrectal ultrasound) guided biopsy individually and in combination and further evaluated the importance extended 12 ...
9
Role of Prostate Volume in the Early Detection of Prostate Cancer in a Cohort with Slowly Increasing Prostate Specific Antigen
... for serum PSA levels more than two times between January 2001 and November 2011 were ...in PSA levels from less than 4 ng/mL to more than 4 ng/mL and underwent transrectal ultrasound guided prostate ...
5
Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
... of Psa and the digital-rectal examination are both limited with regard to their low sensitivity and ...elevated Psa or an abnormal DRE with- out having prostate cancer. a serum Psa measure- ...
6
Evaluation of prostate cancer prevalence in Iranian male population with increased PSA level, a one center experience
... the serum PSA concentration cor- related directly with the subject’s age and prostatic ...age-related PSA cutoff point was ...The serum PSA levels and prostate volume are age- and ...
5
Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA
... used serum biomarker for early detection of PCa ...of PSA testing, more prostate cancers were discov- ered at early stages [13, ...However, PSA testing has limitations such as low specificity, false ...
8
Prognostic factors and risk stratification in patients with castration-resistant prostate cancer receiving docetaxel-based chemotherapy
... If PSA increased after confirmation of the existence of anti- androgen withdrawal syndrome and alternative antiandro- gen therapy, we judged that prior androgen deprivation therapy was a ...elevated serum ...
8
Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer
... In this study we examined the effects of isocaloric modifications in dietary protein quantity or quality on tumor growth in the human xenograft LuCaP23.1 (CR and AS), LuCaP35V (CR) and WHIM16 BC models. Our findings ...
11
THE EFFECTS OF PISTACIA ATLANTICA ON TESTOSTERONEINDUCED BENIGN PROSTATIC HYPERPLASIA IN RATS
... cells. Serum PSA levels increase abnormally in patients with benign prostatic hyperplasia and ...the serum PSA level can show protective effectson benign prostatic ...the serum ...
7
Serum Fucosylated Prostate-specific Antigen (PSA) Improves the Differentiation of Aggressive from Non-aggressive Prostate Cancers
... of serum PSA has been considered an indicator of a clinical aggressive tumor, our study and others have shown that not all patients with aggressive tumors have elevated levels of serum ...of ...
10
Original Article Age-specific reference range of prostate-specific antigen in a population-based single-center study in the north of China
... Abnormal PSA levels were defined as the concentration >4 ng/mL, abnormal percent free PSA (% fPSA) was defined as ...mal PSA density (PSAD) was defined as ...(1) serum PSA level ≤4 ...
7
Analysis of Immunohistochemical Expression of CD10 in the Lesions of Prostate
... A total sample of 40 cases were analysed during the period of June 2012 to May 2016.We categorized the total cases as benign, premalignant and malignant lesions, their age wise distribution was analysed. The cases of ...
115
Key words
... It is highly possible that these drugs, effica- cious in primary chemoprevention, will be effec- tive also in stabilizing the existing cancer during secondary chemoprevention [11]. Both 5-alpha re- ductase inhibitor ...
6
Improved prediction of prostate cancer recurrence through systems pathology
... experienced PSA recurrence within 5 years that were correctly predicted; specificity was defined as the percentage of patients who did not experience a PSA recurrence within 5 years that were correctly ...
9